United States Biologics and Biosimilars Market Report 2016

Publisher Name :
Date: 17-Oct-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Biologics and Biosimilars

Revenue, means the sales value of Biologics and Biosimilars

This report studies sales (consumption) of Biologics and Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer

- Roche

- Amgen

- AbbVie

- Sanofi

- Johnson & Johnson

- Novo Nordisk

- Novartis

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Biologics

- Biosimilars

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Biologics and Biosimilars in each application, can be divided into

- Tumor

- Diabetes

- Cardiovascular

- Others

United States Biologics and Biosimilars Market Report 2016

Table of Contents
United States Biologics and Biosimilars Market Report 2016
1 Biologics and Biosimilars Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
1.2.1 Biologics
1.2.2 Biosimilars
1.2.3 Type III
1.3 Application of Biologics and Biosimilars
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biologics and Biosimilars (2011-2021)
1.4.1 United States Biologics and Biosimilars Sales and Growth Rate (2011-2021)
1.4.2 United States Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
2 United States Biologics and Biosimilars Competition by Manufacturers
2.1 United States Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biologics and Biosimilars Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biologics and Biosimilars Average Price by Manufactures (2015 and 2016)
2.4 Biologics and Biosimilars Market Competitive Situation and Trends
2.4.1 Biologics and Biosimilars Market Concentration Rate
2.4.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Biologics and Biosimilars Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Biologics and Biosimilars Sales and Market Share by Type (2011-2016)
3.2 United States Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
3.3 United States Biologics and Biosimilars Price by Type (2011-2016)
3.4 United States Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)
4 United States Biologics and Biosimilars Sales (Volume) by Application (2011-2016)
4.1 United States Biologics and Biosimilars Sales and Market Share by Application (2011-2016)
4.2 United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Biologics and Biosimilars Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Biologics and Biosimilars Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Roche
5.2.2 Biologics and Biosimilars Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Amgen
5.3.2 Biologics and Biosimilars Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 AbbVie
5.4.2 Biologics and Biosimilars Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi
5.5.2 Biologics and Biosimilars Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson
5.6.2 Biologics and Biosimilars Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
5.7.2 Biologics and Biosimilars Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Novartis
5.8.2 Biologics and Biosimilars Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
6 Biologics and Biosimilars Manufacturing Cost Analysis
6.1 Biologics and Biosimilars Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biologics and Biosimilars
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Biologics and Biosimilars Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Biologics and Biosimilars Market Forecast (2016-2021)
10.1 United States Biologics and Biosimilars Sales, Revenue Forecast (2016-2021)
10.2 United States Biologics and Biosimilars Sales Forecast by Type (2016-2021)
10.3 United States Biologics and Biosimilars Sales Forecast by Application (2016-2021)
10.4 Biologics and Biosimilars Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure United States Sales Market Share of Biologics and Biosimilars by Type in 2015
Figure Biologics Picture
Figure Biosimilars Picture
Table Application of Biologics and Biosimilars
Figure United States Sales Market Share of Biologics and Biosimilars by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Others Examples
Figure United States Biologics and Biosimilars Sales and Growth Rate (2011-2021)
Figure United States Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Table United States Biologics and Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table United States Biologics and Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers
Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers
Table United States Biologics and Biosimilars Revenue by Manufacturers (2015 and 2016)
Table United States Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 United States Biologics and Biosimilars Revenue Share by Manufacturers
Table United States Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table United States Biologics and Biosimilars Sales by Type (2011-2016)
Table United States Biologics and Biosimilars Sales Share by Type (2011-2016)
Figure United States Biologics and Biosimilars Sales Market Share by Type in 2015
Table United States Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
Table United States Biologics and Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2011-2016)
Table United States Biologics and Biosimilars Price by Type (2011-2016)
Figure United States Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)
Table United States Biologics and Biosimilars Sales by Application (2011-2016)
Table United States Biologics and Biosimilars Sales Market Share by Application (2011-2016)
Figure United States Biologics and Biosimilars Sales Market Share by Application in 2015
Table United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)
Figure United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biologics and Biosimilars Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Biologics and Biosimilars Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biologics and Biosimilars Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Biologics and Biosimilars Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Biologics and Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biologics and Biosimilars Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biologics and Biosimilars Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biologics and Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure United States Biologics and Biosimilars Production and Growth Rate Forecast (2016-2021)
Figure United States Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table United States Biologics and Biosimilars Production Forecast by Type (2016-2021)
Table United States Biologics and Biosimilars Consumption Forecast by Application (2016-2021)
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Global Letrozole Market Professional Survey Report 2016
    Published: 02-Dec-2016        Price: US 3500 Onwards        Pages: 106
    Notes: Production, means the output of Letrozole Revenue, means the sales value of Letrozole This report studies Letrozole in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manuf......
  • Europe Intravenous Solution Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Intravenous Solution Revenue, means the sales value of Intravenous Solution This report studies sales (consumption) of Intravenous Solution in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Baxter (US) - Braun Medical Inc. (US) - AIN MEDIC......
  • Global Penicillin Market Professional Survey Report 2016
    Published: 02-Dec-2016        Price: US 3500 Onwards        Pages: 112
    Notes: Production, means the output of Penicillin Revenue, means the sales value of Penicillin This report studies Penicillin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each ma......
  • China Vitro Diagnostics Reagent Market Research Report 2016
    Published: 02-Dec-2016        Price: US 3200 Onwards        Pages: 112
    Notes: Sales, means the sales volume of Vitro Diagnostics Reagent Revenue, means the sales value of Vitro Diagnostics Reagent This report studies Vitro Diagnostics Reagent in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Roche - Siemens - Abbott - Beckman - BD - Johnson & Johnson - BioMerieux - Bio-Rad ......
  • Europe Dolutegravir Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Dolutegravir Revenue, means the sales value of Dolutegravir This report studies sales (consumption) of Dolutegravir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - GSK - DESANO Market Segment by Countries, this report splits Euro......
  • United States, EU, Japan, China, India and Southeast Asia Scar Treatment Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 107
    Notes: Production, means the output of Scar Treatment Revenue, means the sales value of Scar Treatment This report studies the global Scar Treatment market, analyzes and researches the Scar Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Avita Medical - CCA Industries - Enaltus - Oculus Innovative Sciences - Pacifi......
  • Europe Glimepiride Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Glimepiride Revenue, means the sales value of Glimepiride This report studies sales (consumption) of Glimepiride in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Sanofi-Aventis - Wanbang Biopharmaceuticals - Cspc Pharmaceutical - T......
  • Global Calcium Channel Blocker Market Research Report 2016
    Published: 02-Dec-2016        Price: US 2900 Onwards        Pages: 103
    Notes: Production, means the output of Calcium Channel Blocker Revenue, means the sales value of Calcium Channel Blocker This report studies Calcium Channel Blocker in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Pfizer - Aventis - Searle - Bayer - AstraZenec......
  • Global Autolytic Debridement Sales Market Report 2016
    Published: 02-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Autolytic Debridement Revenue, means the sales value of Autolytic Debridement This report studies sales (consumption) of Autolytic Debridement in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Advanced Medical Solutions Group plc (UK) - ArthroCare Corporatio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs